Phase II study of AJG511 in patients with active ulcerative colitis
Phase 2
- Conditions
- lcerative colitis
- Registration Number
- JPRN-jRCT2080222245
- Lead Sponsor
- Ajinomoto Pharmaceuticals Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with lesions not exceeding the segment from the rectum to the sigmoid colon
Exclusion Criteria
- Patients with infections and deep mycosis against which no effective antimicrobial is available.
- Patients with intolerance to or a history of allergic reaction to budesonide.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Remission rate
- Secondary Outcome Measures
Name Time Method